Published on 20 Dec 2024 on Investing.com
Cabaletta Bio's SWOT analysis: autoimmune CAR-T stock faces challenges,...
Cabaletta Bio, Inc. (NASDAQ:CABA), with a market capitalization of $119.5 million, is at the...
NYSE.CARS price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free